CEA-Tricom: Began Phase I study

Therion Biologics Corp., Cambridge, Mass.
Product: CEA-Tricom
Business: Cancer
Therapeutic

Read the full 105 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE